EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/29/2025
Back to search
Official data from USPTO
FRED HUTCH CANCER CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
FRED HUTCH CANCER CENTER
ST13
US500000097437754Class
1, 5, 9, 16, 35, 36, 41, 42, 44, 45
Filing
97437754
Registration
7995226
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
11/05/2025
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9, 16, 35, 36, 41, 42, 44, 45
Filing date
06/01/2022
Registration date
10/21/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
11/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/26/2023
First use in commerce
10/26/2023
Drawing code
4
Owner type
99
Owner location
Seattle, WA
Examiner
BLAKESLEE,RICHARD A
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
F. C. (pessoa física)
Representatives
Tiffany Connors Ballard Spahr LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 16Class 35Class 36Class 41Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents and monoclonal antibodies for in vitro scientific or research use
Class 5
Diagnostic reagents and monoclonal antibodies for medical use
Class 9
Downloadable electronic publications in the nature of newsletterspamphletsbrochuresmagazinesinstruction sheetsmanuals in the fields of researchpreventiondetectiontreatmentcure of cancerHIV/AIDSother diseasesrelated medical and public health problems
Class 16
Printed publicationsnewsletterspamphletsbrochuresmagazinesinstruction sheetsmanuals in the fields of researchpreventiondetectiontreatmentcure of cancerHIV/AIDSother diseasesrelated medical and public health problems
Class 35
Promoting public awareness about cancer; promoting public awareness about researchpreventiondiagnosistreatmentcure of cancerHIV/AIDSpublic health problemsother diseases; providing a website featuring information regarding events promoting public awareness of cancer; providing a website featuring information regarding events promoting public awareness of researchpreventiondiagnosistreatmentcure of cancerHIV/AIDSpublic health problemsother diseases; providing medical referralsbusiness administrative services for medical referrals; retail pharmacy services
Class 36
Charitable fund raising in the area of researchpreventiondetectiontreatmentcure of cancer and related medical and public health problems
Class 41
Educational servicesdeveloping and disseminating educational materials and programs of others to healthcare providers and patients in the fields of preventiondiagnosistreatmentcure of cancerHIV/AIDSpublic health problemsother diseases; educational servicesproviding classesseminarsworkshopsconferences in the fields of preventiondiagnosistreatmentcure of cancerHIV/AIDSpublic health problemsother diseasesdistribution of educational materials in connection therewith; providing a website featuring non-downloadable articles in the fields of preventiondiagnosistreatmentcure of cancerHIV/AIDSother diseasespublic health problems; providing on-line non-downloadable publications in the nature of newsletterspamphletsbrochuresmagazinesinstruction sheetsmanuals in the fields of researchpreventiondetectiontreatmentcure of cancer
Class 42
Consulting related to medical research in the fields of cancer and related medical conditions; medical and scientific research in the fields of cancer treatment and diagnosis; scientific research for medical purposes in the fields of cancerinfectious diseases and related medical and public health problems; medical laboratory services
Class 44
Medical consultationsconsultation services in the fields of preventiondiagnosistreatmentcure of cancerHIV/AIDSother diseasespublic health problems; medical services; medical consulting servicesproviding medical second opinionspreventiondiagnostictreatment protocols for cancer and related medical conditions; medical consulting servicesconsulting on the treatment of cancer and other diseasesdisease managementdisease preventionearly detection of diseaseperforming standardized diagnosis of diseasestaging and treatment of diseasemedical care and medical care assessmentpatient care management; medical servicesmedical counselingdiagnostic testingtreatment services for patients with cancer and related medical conditions; medical consulting services in the area of clinical programs for bone marrow and stem cell transplants; medical servicesthe treatment of cancer and other diseasesdisease managementdisease preventionearly detection of diseaseperforming standardized diagnosis of diseasestaging and treatment of diseasemedical care and medical care assessmentcounseling; medical servicespatient networking in the nature of providing a website via a global computer network featuring information in the fields of healthcancer treatmentcancer recovery and survival; medical and health clinic servicesproviding clinical care for patients with cancer and related medical conditionsHIV/AIDSother diseases; outpatient medical services; home health care services; medical diagnosis servicesperforming diagnosis of cancerHIV/AIDS and related medical and public health problems; medical screening services for cancerHIV/AIDSrelated medical and public health problems; medical imaging services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; provision of health care and medical services by health care professionals via the Internet or telecommunication networks; medical servicesmedical and psychological counseling services for patients and families of patients; health care servicesdisease prevention in the nature of medical screeningsclinical diagnosis and wellness programs; dietary and nutritional guidance services; providing a website featuring information in the fields of preventiondiagnosistreatmentthe cure of cancerHIV/AIDSpublic health problemsother disease
Class 45
Providing personal support services for patients and families of patients with canceremotional counseling and emotional support; providing patient advocate services in the fields of preventiondiagnosistreatment and cure of cancerHIV/AIDSpublic health problemsother diseases; providing a website via a global computer network featuring supportive personal stories on the subjects of healthcancercancer recovery and survival; patient networking in the nature of online social networking services in the field of medical care; community outreach and patient counseling regarding disease prevention and wellness programsorganizing and conducting in-person and online support groups in the field of cancer for patients and families of patients with cancer
Publications
History of USPTO decisions and trademark events.
55 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/29/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/29/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/29/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/29/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/29/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/29/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/05/2025
GNFR
FINAL REFUSAL E-MAILED
08/05/2025
CNFR
SU - FINAL REFUSAL - WRITTEN
08/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/02/2025
ALIE
ASSIGNED TO LIE
07/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/17/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
04/02/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
04/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2025
GNRT
NON-FINAL ACTION E-MAILED
01/06/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/06/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/13/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/13/2024
IUAF
USE AMENDMENT FILED
10/02/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/29/2024
EX2G
SOU EXTENSION 2 GRANTED
07/29/2024
EXT2
SOU EXTENSION 2 FILED
07/29/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/29/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/01/2024
EX1G
SOU EXTENSION 1 GRANTED
01/30/2024
EXT1
SOU EXTENSION 1 FILED
01/30/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/21/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/21/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/21/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
02/21/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/21/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/21/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/10/2023
GNRT
NON-FINAL ACTION E-MAILED
02/10/2023
CNRT
NON-FINAL ACTION WRITTEN
02/10/2023
DOCK
ASSIGNED TO EXAMINER
02/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2022
NWAP
NEW APPLICATION ENTERED
06/04/2022
Continuous trademark protection
Get notified about every new filing that threatens FRED HUTCH CANCER CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.